Quantcast
Channel: Healthcare Press Releases - EmailWire Press Release Distribution Services
Viewing all 32432 articles
Browse latest View live

Protection Gloves for Pharmaceutical Applications Market by 2023 Analyzed Report

October 11, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 11, 2018 ) The global market size of Protection Gloves for Pharmaceutical Applications Market is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
*North America
*South America
*Asia & Pacific
*Europe
*MEA (Middle East and Africa)

Get Sample Copy of this Report at https://www.researchreportsinc.com/sample-request?id=67428

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Protection Gloves for Pharmaceutical Applications as well as some small players. The compnaies include:

AMMEX, Ansell, ARISTA, BLUESAIL, Cardinal Health, COMASEC, Dengsheng, Dynarex, Dyneema, Globus, Hartalega, HL Rubber Industries, Honeywell, HONGRAY, Ironclad, Jaysun Glove, Jiangsu Cureguard Glove, Ki et al.

The information for each competitor includes:
*Company Profile
*Main Business Information
*SWOT Analysis
*Sales, Revenue, Price and Gross Margin
*Market Share

Table of Content
TABLE OF CONTENTS
Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Methodology
3.2.1 Data Collection
3.2.2 Data Analysis
3.2.3 Data Validation
3.3 Research Sources
3.3.1 Primary Sources
3.3.2 Secondary Sources
3.3.3 Assumptions

Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Protection Gloves for Pharmaceutical Applications Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Trading Analysis
8.1 Export of Protection Gloves for Pharmaceutical Applications by Region
8.2 Import of Protection Gloves for Pharmaceutical Applications by Region
8.3 Balance of Trade

Chapter 9 Historical and Current Protection Gloves for Pharmaceutical Applications Market in North America (2013-2018)
9.1 Protection Gloves for Pharmaceutical Applications Supply
9.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

Chapter 10 Historical and Current Protection Gloves for Pharmaceutical Applications Market in South America (2013-2018)
10.1 Protection Gloves for Pharmaceutical Applications Supply
10.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

Chapter 11 Historical and Current Protection Gloves for Pharmaceutical Applications Market in Asia & Pacific (2013-2018)
11.1 Protection Gloves for Pharmaceutical Applications Supply
11.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

Chapter 12 Historical and Current Protection Gloves for Pharmaceutical Applications Market in Europe (2013-2018)
12.1 Protection Gloves for Pharmaceutical Applications Supply
12.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

Chapter 13 Historical and Current Protection Gloves for Pharmaceutical Applications Market in MEA (2013-2018)
13.1 Protection Gloves for Pharmaceutical Applications Supply
13.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

Chapter 14 Summary for Global Protection Gloves for Pharmaceutical Applications Market (2013-2018)
14.1 Protection Gloves for Pharmaceutical Applications Supply
14.2 Protection Gloves for Pharmaceutical Applications Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

Chapter 15 Global Protection Gloves for Pharmaceutical Applications Market Forecast (2019-2023)
15.1 Protection Gloves for Pharmaceutical Applications Supply Forecast
15.2 Protection Gloves for Pharmaceutical Applications Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

Chapter 16 Company Profile(AMMEX, Ansell, ARISTA, BLUESAIL, Cardinal Health, COMASEC, Dengsheng, Dynarex, Dyneema, Globus, Hartalega, HL Rubber Industries, Honeywell, HONGRAY, Ironclad, Jaysun Glove, Jiangsu Cureguard Glove, Ki et al.)
16.1 Company A
16.1.1 Company Profile
16.1.2 Main Business and Protection Gloves for Pharmaceutical Applications Information
16.1.3 SWOT Analysis of Company A
16.1.4 Company A Protection Gloves for Pharmaceutical Applications Sales, Revenue, Price and Gross Margin (2013-2018)

Have Any Query? Ask Our Experts @ https://researchreportsinc.com/enquiry?id=67428

We also can offer customized report to fulfill special requirements of our clients.


Shubham Goel
8554192424
sales@researchreportsinc.com

Source: EmailWire.Com
↧
Search
↧

Pulmonary Arterial Hypertension (PAH) Therapeutics Market Trends and Drivers in 2023 Report

October 11, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 11, 2018 ) The global market size of Pulmonary Arterial Hypertension (PAH) Therapeutics Market is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
*North America
*South America
*Asia & Pacific
*Europe
*MEA (Middle East and Africa)

Get Sample Copy of this Report at https://www.researchreportsinc.com/sample-request?id=67432

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Pulmonary Arterial Hypertension (PAH) Therapeutics as well as some small players. The companies include:

Actelion Pharmaceuticals Ltd. (Switzerland), Arena Pharmaceuticals, Inc. (US), Bayer HealthCare Pharmaceuticals (Germany), Cipla Limited (India), Daiichi Sankyo Co., Ltd. (Japan), Eli Lilly and Compa et al.

The information for each competitor includes:
*Company Profile
*Main Business Information
*SWOT Analysis
*Sales, Revenue, Price and Gross Margin
*Market Share

TABLE OF CONTENTS
Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Methodology
3.2.1 Data Collection
3.2.2 Data Analysis
3.2.3 Data Validation
3.3 Research Sources
3.3.1 Primary Sources
3.3.2 Secondary Sources
3.3.3 Assumptions

Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Trading Analysis
8.1 Export of Pulmonary Arterial Hypertension (PAH) Therapeutics by Region
8.2 Import of Pulmonary Arterial Hypertension (PAH) Therapeutics by Region
8.3 Balance of Trade

Chapter 9 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in North America (2013-2018)
9.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
9.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

Chapter 10 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in South America (2013-2018)
10.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
10.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

Chapter 11 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in Asia & Pacific (2013-2018)
11.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
11.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

Chapter 12 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in Europe (2013-2018)
12.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
12.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

Chapter 13 Historical and Current Pulmonary Arterial Hypertension (PAH) Therapeutics Market in MEA (2013-2018)
13.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
13.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

Chapter 14 Summary for Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market (2013-2018)
14.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply
14.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

Chapter 15 Global Pulmonary Arterial Hypertension (PAH) Therapeutics Market Forecast (2019-2023)
15.1 Pulmonary Arterial Hypertension (PAH) Therapeutics Supply Forecast
15.2 Pulmonary Arterial Hypertension (PAH) Therapeutics Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

Chapter 16 Company Profile(Actelion Pharmaceuticals Ltd. (Switzerland), Arena Pharmaceuticals, Inc. (US), Bayer Health Care Pharmaceuticals (Germany), Cipla Limited (India), Daiichi Sankyo Co., Ltd. (Japan), Eli Lilly and Compa et al.)
16.1 Company A
16.1.1 Company Profile

Have Any Query? Ask Our Experts @ https://researchreportsinc.com/enquiry?id=67432

We also can offer customized report to fulfill special requirements of our clients.


Shubham Goel
8554192424
sales@researchreportsinc.com

Source: EmailWire.Com
↧

Cancer Stem Cell Market : Know The Current and Future Prospects of the Industry from 2018 to 2023

October 11, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 11, 2018 ) Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.

This research study presents an all-inclusive assessment of the global Cancer Stem Cell Market, considering various industry parameters, such as the manufacturing capacity, product pricing, demand, supply, sales dynamics, returns on investments (RoI), and the growth rate of the overall market. The main objective of this research study is to provide a clear understanding of the global Cancer Stem Cell market to the participants and assist them in creating crucial strategies to gain an edge over their competitors.

Get Sample Copy of this Report @ https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/request-sample

Scope of the Report:
This report studies the Cancer Stem Cell market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Stem Cell market by product type and applications/end industries.

North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.

Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.

Market Segment by Companies, this report covers: Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Miltenyi Biotec, PromoCell GmbH, MacroGenics, Inc., OncoMed Pharmaceuticals, Inc., Irvine Scientific, STEMCELL Technologies Inc., Sino Biological Inc., BIOTIME, Inc.

Market Segment by Regions, regional analysis covers
• North America
• Europe
• Asia-Pacific
• Middle East and Africa

Get a discount on this research report @ https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/purchase-enquiry

Market Segment by Type, covers
• Cell Culturing
• Cell Separation
• Cell Analysis
• Molecular Analysis
• Others

Market Segment by Applications, can be divided into
• Stem Cell Based Cancer Therapy
• Targeted CSCs

There are 15 Chapters to deeply display the global Cancer Stem Cell market.
• Chapter 1, to describe Cancer Stem Cell Introduction, product scope, market overview, market opportunities, market risk, market driving force;
• Chapter 2, to analyze the top manufacturers of Cancer Stem Cell, with sales, revenue, and price of Cancer Stem Cell, in 2016 and 2017;
• Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
• Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Stem Cell, for each region, from 2013 to 2018;
• Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
• Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
• Chapter 12, Cancer Stem Cell market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
• Chapter 13, 14 and 15, to describe Cancer Stem Cell sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Access full report Description, TOC and Table of Figure @: https://www.researchbeam.com/global-cancer-stem-cell-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market

About Us:

Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com



Research Beam
+1 (800) 910-6452
help@researchbeam.com

Source: EmailWire.Com
↧

Future Growth of Hospital Asset Management Market Research Report 2018-2023 By Segment, Trend & Top Key Players

October 11, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 11, 2018 ) By improving maintenance practices, helping hospitals be more compliant to industry standards, and ensuring robust sanitation and tracking methods, hospital assest management methods can increase its productivity and improve patient prospects dramatically.

A report titled “Global Hospital Asset Management Market” has been lately added to the Research Beam’s extensive database. Their repository depicts the expert documentation of reports based on different markets and Global Hospital Asset Management Market is one of them. This survey has outlined some of the key trends, promising advancements that the future holds, growing opportunities, latest technological advancements, and competitive landscape in major regions. It estimates the growth rate of various segments over the forecast period (2023).

Get Sample Copy of this Report @ https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/request-sample

Scope of the Report:
This report studies the Hospital Asset Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Asset Management market by product type and applications/end industries.

Global hospital asset management market is expected to witness a lucrative growth during the forecast period owing to the increasing incidences of drug counterfeiting along with rising issues in supply chain management.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Asset Management.

Market Segment by Companies, this report covers: Tyco international Ltd., IBM corporation, Awarepoint corporation, Infor, Motorola solutions Inc., GE healthcare, Ekahau Inc., Siemens healthcare, Vizbee RFID systems Ltd., Sonitor technologies Inc., Versus technology Inc., Zebra technologies corporation, Trimble navigation Ltd, AeroScout Inc.

Market Segment by Regions, regional analysis covers
• North America
• Europe
• Asia-Pacific
• Middle East and Africa

Get a discount on this research report @ https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market/purchase-enquiry

Market Segment by Type, covers
• Real-time location systems (RTLS)
• Radio-frequency identification (RFID)
• Ultrasound
• Infrared

Market Segment by Applications, can be divided into
• Patient management
• Staff management
• Instrument management
• Supply chain management

There are 15 Chapters to deeply display the global Hospital Asset Management market.
• Chapter 1, to describe Hospital Asset Management Introduction, product scope, market overview, market opportunities, market risk, market driving force;
• Chapter 2, to analyze the top manufacturers of Hospital Asset Management, with sales, revenue, and price of Hospital Asset Management, in 2016 and 2017;
• Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
• Chapter 4, to show the global market by regions, with sales, revenue and market share of Hospital Asset Management, for each region, from 2013 to 2018;
• Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
• Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
• Chapter 12, Hospital Asset Management market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
• Chapter 13, 14 and 15, to describe Hospital Asset Management sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Access full report Description, TOC and Table of Figure @: https://www.researchbeam.com/global-hospital-asset-management-2018-by-manufacturers-countries-type-and-application-forecast-to-2023-market

About Us:

Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.


Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com



Research Beam
+1 (800) 910-6452
help@researchbeam.com

Source: EmailWire.Com
↧

Global Lassa Fever Industry 2018 Market Research Report: Product Price, Market Size, Share and Growth Rate of Each Type

October 16, 2018, 12:00 am
$
0
0
(EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018, provides an overview of the Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline landscape.

Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arena virus family of viruses. It is transmitted to humans from contacts with food or household items contaminated with rodent excreta. Symptoms include fever, headache, chills, back pain, weight loss, swollen neck, rashes and bleeding.

Key Players:
• Celgene Corp
• Etubics Corp
• GeoVax Labs Inc
• Inovio Pharmaceuticals Inc
• Kineta Inc
• Profectus BioSciences Inc
• Themis Bioscience GmbH
• Toyama Chemical Co Ltd

Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332474

Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical, Discovery and Unknown stages are 1, 9, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332474

Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease)

Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/lassa-fever-lassa-hemorrhagic-fever-pipeline-review-h2-2018

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com

Source: EmailWire.Com
↧
↧

Global Epstein-Barr Virus (HHV-4) Infections Industry 2018 Market Research Report: Product Price, Market Size, Share and Growth Rate of Each Type

October 16, 2018, 12:00 am
$
0
0
(EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018, provides an overview of the Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline landscape.

Epstein-Barr virus (EBV) or human herpes virus 4 virus is a member of the Herpesviridae family. It is one of the most common human viruses to cause cancer in humans and is associated with a wide range of human cancers originating from epithelial cells, lymphocytes and mesenchymal cells. It spreads most commonly through bodily fluids. It can also spread through blood and semen during sexual contact, blood transfusions, and organ transplantations. Symptoms of EBV infections include fatigue, fever, and inflamed throat, swollen lymph nodes in the neck, enlarged spleen, swollen liver and rash. Treatment includes over-the-counter pain and fever medications to get relief from the symptoms of the disease.

Key Players:
• Advenchen Laboratories LLC
• Atara Biotherapeutics Inc
• Biotron Ltd
• bluebird bio Inc
• Bristol-Myers Squibb Co
• Cell Medica Ltd
• Genocea Biosciences Inc
• Omeros Corp
• Ono Pharmaceutical Co Ltd
• Oxford Vacmedix UK Ltd
• TC BioPharm Ltd
• Tessa Therapeutics Pte Ltd
• Vectorite Biomedical Inc
• Viracta Therapeutics Inc
• Vironika LLC
• ViroStatics srl

Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332476

Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 8, 4, 9 and 7 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 9, 2, 5 and 4 molecules, respectively.

Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332476

Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Epstein-Barr Virus (HHV-4) Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease)

Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Epstein-Barr Virus (HHV-4) Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/epstein-barr-virus-hhv-4-infections-pipeline-review-h2-2018

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com

Source: EmailWire.Com
↧

Global Paroxysmal Nocturnal Hemoglobinuria Industry 2018 Market Research Report: Product Price, Market Size, Share and Growth Rate of Each Type

October 16, 2018, 12:00 am
$
0
0
(EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline landscape.

Paroxysmal nocturnal hemoglobinuria is a rare disease in which red blood cells break down earlier than normal. Symptoms include abdominal pain, back pain, dark urine, easy bruising or bleeding, headache and shortness of breath. The predisposing factors include age, obesity and hormone therapy. Treatment includes surgery, chemotherapy and radiation therapy.

Key Players:
• Achillion Pharmaceuticals Inc
• Akari Therapeutics Plc
• Alexion Pharmaceuticals Inc
• Alnylam Pharmaceuticals Inc
• Amgen Inc
• Apellis Pharmaceuticals Inc
• Chugai Pharmaceutical Co Ltd
• ISU ABXIS Co Ltd
• Novartis AG
• NovelMed Therapeutics Inc
• Omeros Corp
• Ra Pharmaceuticals Inc
• Regeneron Pharmaceuticals Inc

Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332478

Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 3, 6, 4, 1, 8 and 1 respectively.

Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332478

Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders).
- The pipeline guide reviews pipeline therapeutics for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders)

Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/paroxysmal-nocturnal-hemoglobinuria-pipeline-review-h2-2018

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com

Source: EmailWire.Com
↧

Global Acromegaly Industry 2018 Market Research Report: Product Price, Market Size, Share and Growth Rate of Each Type

October 16, 2018, 12:00 am
$
0
0
(EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H2 2018, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape.

Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth and sleep apnea. Treatment includes surgery, dopamine agonists and growth hormone antagonists.

Key Players:
• Aegis Therapeutics LLC
• Amryt Pharma plc
• Antisense Therapeutics Ltd
• Aquestive Therapeutics Inc
• Auritec Pharmaceuticals Inc
• Camurus AB
• Chiasma Inc
• Crinetics Pharmaceuticals Inc
• Daewoong Pharmaceutical Co Ltd
• Dauntless Pharmaceuticals Inc
• DexTech Medical AB
• GeneScience Pharmaceuticals Co Ltd
• Ionis Pharmaceuticals Inc
• Italfarmaco SpA
• leon-nanodrugs GmbH
• Midatech Pharma Plc
• Ono Pharmaceutical Co Ltd
• Strongbridge Biopharma plc
• Sun Pharma Advanced Research Company Ltd

Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332480

Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acromegaly - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Acromegaly (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 7, 5, 7 and 3 respectively.

Acromegaly (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332480

Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Acromegaly (Hormonal Disorders).
- The pipeline guide reviews pipeline therapeutics for Acromegaly (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Acromegaly (Hormonal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Acromegaly (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Acromegaly (Hormonal Disorders)

Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Acromegaly (Hormonal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Acromegaly (Hormonal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/acromegaly-pipeline-review-h2-2018

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com

Source: EmailWire.Com
↧
Search

Global Drug Overdose Industry 2018 Market Research Report: Product Price, Market Size, Share and Growth Rate of Each Type

October 16, 2018, 12:00 am
$
0
0
(EMAILWIRE.COM, October 16, 2018 ) Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Pipeline Review, H2 2018, provides an overview of the Drug Overdose (Toxicology) pipeline landscape.

Drug overdoses occur when a person takes more than the medically recommended dose of a prescription or over-the-counter drug. It can be either accidental or intentional. Symptoms include sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Risk factors include age, gender, mental illness and history of overdose. Treatment includes antidote and activated charcoal.

Key Players:
• Adamis Pharmaceuticals Corp
• Adapt Pharma Ltd
• Crossject SA
• Fab’entech SA
• Icure Pharmaceutical Inc
• Insys Therapeutics Inc
• Klaria Pharma Holding AB
• Opiant Pharmaceuticals Inc
• Orexo AB
• PledPharma AB

Get Sample Copy of this Report@ http://www.orbisresearch.com/contacts/request-sample/2332484

Report Highlights:
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Drug Overdose - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Drug Overdose (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 1, 2, 1, 3, 2 and 6 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

Drug Overdose (Toxicology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2332484

Scope:
- The pipeline guide provides a snapshot of the global therapeutic landscape of Drug Overdose (Toxicology).
- The pipeline guide reviews pipeline therapeutics for Drug Overdose (Toxicology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Drug Overdose (Toxicology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Drug Overdose (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Drug Overdose (Toxicology)

Reasons to buy:
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Drug Overdose (Toxicology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Drug Overdose (Toxicology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get More Access with Full TOC@ http://www.orbisresearch.com/reports/index/drug-overdose-pipeline-review-h2-2018

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.


Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com

Source: EmailWire.Com
↧
↧

Global Moist Snuff Market (2018 – 2023) Comprehensive Overview, Market Shares, And Growth Opportunities By A Research Firm

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Moist Snuff Market Report for 2018-2023.
Moist snuff is a smokeless tobacco product that is consumed by placing it into mouth between the lip and the gum.
Over the next five years, Expert projects that Moist Snuff will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Moist Snuff market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58954

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Fruit Flavors
Mint Flavors
Segmentation by application:
Offline
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58954

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Swedish Match
American Snuff Company
Copenhagen
Skoal
Timberwolf
Husky
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Moist Snuff consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Moist Snuff market by identifying its various subsegments.
Focuses on the key global Moist Snuff manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Moist Snuff with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Moist Snuff submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58954/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Nicotine Pouches Market Sales, Price, Revenue, Gross Margin And Share 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Nicotine Pouches Market Report for 2018-2023.
Nicotine Pouches are tobacco derived nicotine products that come with a chewing gum base and the nicotine is extracted from the plant nicotiana tabacum.
Over the next five years, Expert projects that Nicotine Pouches will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotine Pouches market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58955

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Fruit Flavours
Mint Flavours
Segmentation by application:
Offline
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58955

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Swedish Match
Chill of Sweden, Inc.
Dryft
The Art Factory AB (POSE）

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Nicotine Pouches consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Nicotine Pouches market by identifying its various subsegments.
Focuses on the key global Nicotine Pouches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58955/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Global Chewing Tobacco Market 2018 - Industry Analysis & Future Development Till 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Chewing Tobacco Market Report for 2018-2023.
Chewing tobacco is a type of tobacco derived product that placed between the cheek and gum. It usually packaged either as loose tobacco leaves, leaves compressed into a small, brick-like shape called a plug, or braids of leaves called a twist.
Over the next five years, Expert projects that Chewing Tobacco will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Chewing Tobacco market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58956

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Fruit Flavours
Mint Flavours
Segmentation by application:
Offline
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-LPI-RCG-58956

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Swedish Match
Tough Guy
Stoker's Chew
J.D's Blend
Levi Garrett
Beech-Nut
Starr
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Chewing Tobacco consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Chewing Tobacco market by identifying its various subsegments.
Focuses on the key global Chewing Tobacco manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58956/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Global Snuff Market Forecast (2018-2023) Report: By Regions, Type and Application with Sales and Revenue Analysis

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Snuff Market Report for 2018-2023.
Snuff is finely cut or ground tobacco.
Over the next five years, Expert projects that Snuff will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Snuff market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/RCG/QBI-LPI-RCG-58957

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Moist Snuff
Dry Snuff
Segmentation by application:
Supermarket
Tobacco Store
Online

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/RCG/QBI-LPI-RCG-58957

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Swedish Match
American Snuff Company
Copenhagen
Skoal
Timberwolf
Husky
Imperial Tobacco Group
Reynolds American
British American Tobacco
Japan Tobacco
Altria

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Snuff consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Snuff market by identifying its various subsegments.
Focuses on the key global Snuff manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Direct Purchase@ https://www.qurateresearch.com/report/buy/RCG/QBI-LPI-RCG-58957/



Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧
↧

Asia Pacific Healthcare Analytics Market is anticipated to be valued at USD 4.42 Billion by 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) Overview:

Health Analytics encompasses several technologies, methods, and skills used to synthesize and analyze health care data from a wide range of health industries, in order to disentangle trends and gain ideas for improving health care outcomes. The analysis of medical care has increasingly played a vital role in health systems around the world to improve patient outcomes and improve the quality of care at an affordable cost. On the other hand, health care analysis provides health institutions with crucial knowledge about income and risk models.

View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/request-sample

Asia Pacific Healthcare Analytics Market size was around USD 1.79 billion in 2018. It is expected to grow at a CAGR of 19.85% to reach USD 4.42 billion by 2023.

Drivers and Restraints:

Incorporation of big analytics in the medical field, technological advancements, continuous government initiatives, high developed infrastructure, concerns about confidentiality of information, better quality outcomes. Restraints of the market are cultural barriers, dearth of skilled workforce and security issues.

To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/

Geographic Segmentation

The Asia Pacific Healthcare Analytics market has geographically segmented into China, India, Japan, South Korea, and Australia. Asia market is the fastest growing market.

Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-healthcare-analytics-market-53/customize-report

Major companies in the market are SAS Institute, Inc., Optum, Inc., IBM Corporation, Truven Health Analytics Inc., Cerner Corporation, Verisk Analytics, Inc., McKesson Corporation, Allscripts Health Solutions, Oracle Corporation, MedeAnalytics, Inovalon, Inc. and Health Catalyst.

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626


Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com

Source: EmailWire.Com
↧

Array Instruments Market, 2023 – Market Outlook, Competitive Analysis and Industry Trends.

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) An array is the technology used in laboratories that quantitatively and simultaneously monitors the expression of thousand genes. The high-throughput approach of microarrays help locate mutations in genotype, measure and detect gene expressions at the mRNA or at the protein level, and locate chromosomal expressions.
The global array instruments market can be divided into three segments: DNA microarrays, protein microarrays, and others including tissue microarrays and cell microarrays. This report covers the present scenario and the growth prospects of the global array instruments market for the period 2015–2019. To calculate the market size, the report considers revenue generated from sales of three applications used by life sciences companies, R&D institutes, and diagnostic laboratories.
Over the next five years, Expert projects that Array Instruments will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58875

This report presents a comprehensive overview, market shares, and growth opportunities of Array Instruments market by product type, application, key manufacturers and key regions.

To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Affymetrix
Agilent Technologies
Illumina
Arrayit
Asterand
Laboratory Corporation of America Holdings
OriGene Technologies
Orla Protein Technologies
Oxford Gene Technology
Partek
Pepscan
Perkin Elmer
Phalanx Biotech Group
ProteoGenix
Qiagen
RayBiotech
Retrogenix
Luminex
Meso Scale Diagnostics
ingyuan Medicare Development Company
Novus Biologicals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58875


Segmentation by product type:
DNA Microarrays
Protein Microarrays
Others

Segmentation by application:
Molecular Biolog
Cell Biology
Genetics
Molecular Pathology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries


Purchase Report@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58875/

Research objectives
To study and analyze the global Array Instruments consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Array Instruments market by identifying its various subsegments.
Focuses on the key global Array Instruments manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Array Instruments with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Array Instruments submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.



Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧
Search

Industrial Wearable Devices Market Share, Statistics, Trends, Segmentation Analysis and Forecast to 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) Wearable devices are also known as wearable gadgets, wearable technology or simply wearables. A wearable device is a technology that is worn on the human body. This type of device has become a more common part of the tech world as companies have started to evolve more types of devices that are small enough to wear and that include powerful sensor technologies that can collect and deliver information about their surroundings. A wearable device is often used for tracking a user's vital signs or pieces of data related to health and fitness, location or even his/her biofeedback indicating emotions. Wearable device models may rely on short-range wireless systems such as Bluetooth or local Wi-Fi setups.
Industrial wearable device is designed to improve workplace safety, productivity and efficiency for companies of the industrial sector. These devices must directly aid a worker to perform the task at hand.
Over the next five years,Expert projects that Industrial Wearable Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/ICT/QBI-LPI-ICT-58877


This report presents a comprehensive overview, market shares, and growth opportunities of Industrial Wearable Devices market by product type, application, key manufacturers and key regions.

To calculate the market size, Expert considers value and volume generated from the sales of the following segments:
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Epson
Vuzix
Eurotech
Generalscan
Honeywell
Shenzhen Unique Electronic
Zebra
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/ICT/QBI-LPI-ICT-58877

Segmentation by product type:
Watches
Fabric
Glasses
Fitness Trackers
Sensors

Segmentation by application:
Manufacturing
Healthcare
Media and Entertainment
Sports and Fitness

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Purchase Report@ https://www.qurateresearch.com/report/buy/ICT/QBI-LPI-ICT-58877/


Research objectives
To study and analyze the global Industrial Wearable Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Industrial Wearable Devices market by identifying its various subsegments.
Focuses on the key global Industrial Wearable Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Industrial Wearable Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Industrial Wearable Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.



Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Global Medical Composites Market 2018 - Outlook By Demand, Sales, Revenue Till 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Medical Composites Market Report for 2018-2023.
The major driver stimulating the medical composites market is high demand from diagnostic imaging.
North America is projected to be the fastest-growing market for medical composites in the next five years.
Over the next five years, Expert projects that Medical Composites will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Composites market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58961

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Carbon
Ceramic
Glass Fiber
Segmentation by application:
Diagnostic Imaging
Composites Body Implants
Surgical Instruments
Denta
Microsphere
Tissue Engineering

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58961

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
3M (US)
Royal DSM (Netherlands)
Royal TenCtae
Toray Industries(Japan)
Icotec (Switzerland)
Mitsubishi Rayon (Japan)
Composiflex (US)
Vermont Composites (US)
ACP Composites (US)
Quatro Composites (US)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Medical Composites consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Medical Composites market by identifying its various subsegments.
Focuses on the key global Medical Composites manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Composites with respect to individual growth trends, future prospects, and their contribution to the total market.

Direct Purchase@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58961/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧
↧

Global Medical Imaging Devices Market Report: Know The Key Growth Drivers, Developments And Innovations 2023

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Medical Imaging Devices Market Report for 2018-2023.
The medical imaging device industry has been evolving ever since its inception, with assurance of cost and clinical advantages offered furthering access to a range of imaging modalities in several medical applications.
Over the next five years, Expert projects that Medical Imaging Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Imaging Devices market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/CnM/QBI-LPI-CnM-58964

To calculate the market size, Expert considers value generated from the sales of the following segments:

Segmentation by product type:
Computer Tomography (CT)
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET)
Ultrasound
X-Ray
Others
Segmentation by application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/CnM/QBI-LPI-CnM-58964

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Philips Healthcare
GE Healthcare
Shimadzu
Varian Medical
Siemens Healthineers
Toshiba
Carestream
Aribex
Ziehm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Medical Imaging Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Medical Imaging Devices market by identifying its various subsegments.
Focuses on the key global Medical Imaging Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Imaging Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Medical Imaging Devices submarkets, with respect to key regions (along with their respective key countries).

Direct Purchase@ https://www.qurateresearch.com/report/buy/CnM/QBI-LPI-CnM-58964/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Global Lancet and Lancing Devices Market | Size | Forecast (2018-2023) | Analysis

October 16, 2018, 12:00 am
$
0
0
 



(EMAILWIRE.COM, October 16, 2018 ) This report covers the present scenario (with the base year being 2017) and the growth prospects of Global Lancet and Lancing Devices Market Report for 2018-2023.
A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip.
Over the next five years, expert projects that Lancet and Lancing Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Lancet and Lancing Devices market by product type, application, key manufacturers and key regions.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-58966

To calculate the market size, Expert considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Safety Lancets
Homecare Lancets
Segmentation by application:
Cholesterol Tests
Glucose Tests
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

For Enquiry, Visit@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-58966

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Roche
Lifescan
BD
Panasonic (Bayer)
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Lancet and Lancing Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Lancet and Lancing Devices market by identifying its various subsegments.
Focuses on the key global Lancet and Lancing Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Lancet and Lancing Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Direct Purchase@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-58966/


Nehal Chinoy
+919881074592
nehal@qurateresearch.com

Source: EmailWire.Com
↧

Proliferative Diabetic Retinopathy Market: Key Manufacturers, Regional Growth 2018

October 16, 2018, 12:00 am
$
0
0
 

RnM



(EMAILWIRE.COM, October 16, 2018 ) In 2017, the global Proliferative Diabetic Retinopathy Market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Proliferative Diabetic Retinopathy market based on company, product type, application and key regions.

This report studies the global market size of Proliferative Diabetic Retinopathy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Proliferative Diabetic Retinopathy in these regions.

This research report categorizes the global Proliferative Diabetic Retinopathy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Proliferative Diabetic Retinopathy include manufacturers, suppliers, distributors, intermediaries, and customers.

Request sample of the report @ https://www.reportsandmarkets.com/sample-request/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

The key manufacturers in the Proliferative Diabetic Retinopathy include

Intas Pharmaceuticals
Santen Pharmaceutical
Valeant Pharmaceuticals International
Allergan Plc
Regeneron Pharmaceuticals
Merck KGaA
Cipla
Genentech, Inc. (Roche Holdings)
Novartis
Pfizer
Available Discount on Report @ https://www.reportsandmarkets.com/check-discount/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

Proliferative Diabetic Retinopathy Market Size Split by Type

Anti-VEGF Agents
Corticosteroids

Proliferative Diabetic Retinopathy Market Size Split by Application

Hospitals
Clinics
Others
Purchase Full Report @ https://www.reportsandmarkets.com/checkout?currency=one_user-USD&report_id=2473984

The study objectives of Proliferative Diabetic Retinopathy Market report are:

To study and analyze the global Proliferative Diabetic Retinopathy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Proliferative Diabetic Retinopathy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Proliferative Diabetic Retinopathy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Proliferative Diabetic Retinopathy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Proliferative Diabetic Retinopathy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Click Here for Any Query@ https://www.reportsandmarkets.com/enquiry/global-proliferative-diabetic-retinopathy-market-insights-forecast-to-2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Proliferative Diabetic Retinopathy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

About Us:
Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.

Contact Us:
Sanjay Jain
Manager - Partner Relations & International Marketing
www.reportsandmarkets.com
info@reportsandmarkets.com
Ph: +44-020-3286-9338 (UK)
Ph: +1-214-736-7666 (US)


Sanjay jain
12143771121
sanjay.jain@reportsandmarkets.com

Source: EmailWire.Com
↧
Viewing all 32432 articles
Browse latest View live
More Pages to Explore .....
Search

Latest Images

Nonprofit donates custom home in this East Bay city for Marine injured in...

Nonprofit donates custom home in this East Bay city for Marine injured in...

April 23, 2024, 7:00 am
New private rooms on Tokaido Shinkansen change the way we travel from Tokyo...

New private rooms on Tokaido Shinkansen change the way we travel from Tokyo...

April 22, 2024, 6:00 am
Ukraine bans military from online gambling amid addiction concerns

Ukraine bans military from online gambling amid addiction concerns

April 22, 2024, 5:17 am
ಮಂಡ್ಯದಿಂದ ಸುಮಲತಾ ದೂರ; ಹೆಚ್‌ಡಿಕೆ ಪರ ಪ್ರಚಾರಕ್ಕಿಳಿಯದ ಸಂಸದೆ –ಬರ್ತಾರೆ ನೋಡೋಣ ಎಂದ...

ಮಂಡ್ಯದಿಂದ ಸುಮಲತಾ ದೂರ; ಹೆಚ್‌ಡಿಕೆ ಪರ ಪ್ರಚಾರಕ್ಕಿಳಿಯದ ಸಂಸದೆ –ಬರ್ತಾರೆ ನೋಡೋಣ ಎಂದ...

April 20, 2024, 8:08 pm
OCBC Bank Singapore Offers Up to 2.8% p.a. Fixed Deposit Promotion from 21...

OCBC Bank Singapore Offers Up to 2.8% p.a. Fixed Deposit Promotion from 21...

April 20, 2024, 12:38 pm
National Poetry Month 2024: Maxine Starr

National Poetry Month 2024: Maxine Starr

April 19, 2024, 9:56 am
Vegan Chicken Pot Pie

Vegan Chicken Pot Pie

April 19, 2024, 9:18 am
Firefox UX: On Purpose: Collectively Defining Our Team’s Mission Statement

Firefox UX: On Purpose: Collectively Defining Our Team’s Mission Statement

April 19, 2024, 7:03 am
New $4.5 million East Bay trail path will connect bicyclists, pedestrians to...

New $4.5 million East Bay trail path will connect bicyclists, pedestrians to...

April 18, 2024, 11:05 am
Photographer Gifts for Clients / Print Packaging / 4x6 Photo Box by...

Photographer Gifts for Clients / Print Packaging / 4x6 Photo Box by...

April 17, 2024, 6:48 pm